Farms.com Home   News

Researchers Identify New Enzyme that Infects Plants—Paving the Way for Potential Disease Prevention

Researchers Identify New Enzyme that Infects Plants—Paving the Way for Potential Disease Prevention

By discovering previously unexplored ways in which crop pathogens break through plant cell walls, the scientists have opened up opportunities for developing effective disease control technologies.

The new research, published in Science, describes a family of enzymes found in a microorganism called Phytophthora infestans. The enzymes enable crop pathogens to degrade pectin—a key component of —thereby enabling the pathogens to break through the plant's defences to infect the plant.

Led by biologists and chemists from the University of York, the international team of researchers discovered the new class of enzymes that attack pectin called LPMOs. The team also showed that disabling the gene that encodes this  rendered the pathogen incapable of infecting the host.

P. infestans is known to cause potato late blight, a devastating plant disease that led to widespread starvation in Europe and more than a million deaths in Ireland in the 1840s, in what became known as 'The Great Famine'. Plant infection continues to cause billions of dollars' worth of damage to global crop production each year and continues to threaten world food security.

The identification of this new gene could open up new ways of protecting  from this important group of .

Lead author on the report, Dr. Federico Sabbadin, from the Biology Department's Centre for Novel Agricultural Products (CNAP), at the University of York said: "These new enzymes appear to be important in all plant pathogenic oomycetes, and this discovery opens the way for potentially powerful strategies in crop protection".

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.